Stockscreener 앱 받기
82.68
2.06%
1.67
시간 외 거래:
81.08
-1.60
-1.94%
전일 마감가:
$81.01
열려 있는:
$81.2
하루 거래량:
202.43K
Relative Volume:
0.59
시가총액:
$1.20B
수익:
$1.80M
순이익/손실:
$1.76B
주가수익비율:
0.6967
EPS:
118.674
순현금흐름:
$-149.23M
1주 성능:
+6.56%
1개월 성능:
+44.32%
6개월 성능:
+542.92%
1년 성능:
+456.39%
1일 변동 폭
$79.16
$82.71
1주일 범위
$77.41
$87.83
52주 변동 폭
$10.80
$87.83
인히브릭스 Stock (INBX) Company Profile
명칭
Inhibrx Biosciences Inc
전화
(858) 795-4220
주소
11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA
INBX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INBX
Inhibrx Biosciences Inc
|
82.68 | 1.18B | 1.80M | 1.76B | -149.23M | 118.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.82 | 107.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.32 | 80.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.80 | 57.37B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.93 | 55.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
209.02 | 44.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
인히브릭스 Stock (INBX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-23 | 개시 | JMP Securities | Mkt Perform |
| 2024-01-23 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-03-16 | 개시 | SMBC Nikko | Outperform |
| 2021-09-21 | 개시 | JMP Securities | Mkt Outperform |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2020-09-14 | 개시 | Credit Suisse | Outperform |
| 2020-09-14 | 개시 | Evercore ISI | Outperform |
모두보기
인히브릭스 주식(INBX)의 최신 뉴스
Inhibrx Biosciences stock hits all-time high at 87.4 USD By Investing.com - Investing.com Australia
Inhibrx Biosciences stock hits all-time high at 87.4 USD - Investing.com India
Discipline and Rules-Based Execution in INBX Response - news.stocktradersdaily.com
Will Inhibrx Biosciences Inc. stock deliver shareholder value2025 Key Highlights & Free Real-Time Volume Trigger Notifications - newser.com
What high frequency data says about Inhibrx Biosciences Inc.2025 Market Sentiment & Risk Adjusted Buy and Sell Alerts - newser.com
How high can Inhibrx Biosciences Inc. stock go2025 Valuation Update & Risk Controlled Stock Pick Alerts - newser.com
Multi factor analysis applied to Inhibrx Biosciences Inc.Weekly Gains Report & Weekly Watchlist for Hot Stocks - newser.com
Inhibrx Biosciences Inc. stock daily chart insights2025 Technical Patterns & Free Community Supported Trade Ideas - newser.com
How to recover losses in Inhibrx Biosciences Inc. stock2025 Market Outlook & Safe Capital Growth Tips - newser.com
Inhibrx Biosciences stock rating maintained at Market Perform by Citizens - Investing.com South Africa
Is Inhibrx Biosciences Inc. stock a buy in volatile marketsWeekly Trend Recap & Verified Stock Trade Ideas - newser.com
Will Inhibrx Biosciences Inc. stock pay special dividendsJuly 2025 Recap & Fast Gain Swing Alerts - newser.com
Inhibrx Biosciences Inc (INBX) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews
Why Inhibrx Biosciences Inc. stock appeals to analystsJuly 2025 Price Swings & Daily Chart Pattern Signal Reports - newser.com
What Wall Street predicts for Inhibrx Biosciences Inc. stock priceQuarterly Trade Summary & Weekly Top Gainers Trade List - newser.com
Press Release: Inhibrx Reports Third Quarter 2025 Financial Results - 富途牛牛
Inhibrx Misses Estimates Even As New Cancer Drug Shows Promise - Finimize
Inhibrx Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Earnings Flash (INBX) Inhibrx Biosciences Posts Q3 Loss $2.28 a Share - MarketScreener
Inhibrx Biosciences' Q3 net loss widens, misses EPS estimates - MarketScreener
Inhibrx Biosciences, Inc. SEC 10-Q Report - TradingView
Inhibrx Reports Third Quarter 2025 Financial Results - PR Newswire
[8-K] Inhibrx Biosciences, Inc. Reports Material Event | INBX SEC FilingForm 8-K - Stock Titan
[10-Q] Inhibrx Biosciences, Inc. Quarterly Earnings Report | INBX SEC FilingForm 10-Q - Stock Titan
Inhibrx’s Phase 2 Study on INBRX-109: A Potential Breakthrough in Chondrosarcoma Treatment - MSN
Inhibrx supports CTOS2025 spotlight on chondrosarcoma - Traders Union
Behavioral Patterns of INBX and Institutional Flows - news.stocktradersdaily.com
What does recent volatility data suggest for Inhibrx Biosciences Inc.Quarterly Profit Review & Consistent Income Trade Ideas - newser.com
Is Inhibrx Biosciences Inc. stock resilient to inflationEarnings Overview Summary & Accurate Intraday Trading Signals - newser.com
Tick level data insight on Inhibrx Biosciences Inc. volatilityJuly 2025 Recap & AI Enhanced Trading Alerts - newser.com
Will Inhibrx Biosciences Inc. stock benefit from sector rotation2025 AllTime Highs & Free Daily Entry Point Trade Alerts - newser.com
인히브릭스 (INBX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.53%
1.88%
자본화:
|
볼륨(24시간):